Evidence Hub

Editorial comment to A case of recurrence of renal cell carcinoma after simultaneous radical nephrectomy and cadaver renal transplant

G. Anan

IJU Case Reports, 2022

Abstract

1 Chadban SJ, Ahn C, Axelrod DA et al. KDIGO clinical practice guideline on the evaluation and management of candidates for renal transplantation. Transplantation 2020; 104: S11–103. 2 Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am. J. Transplant. 2001; 1: 3–95. 3 Neeff HP, Pisarski P, Tittelbach-Helmrich D et al. One hundred consecutive renal transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 2013; 28: 466–71. 4 Schrock W, Dube H, Farrow J et al. Attenuated antihypertensive requirements in autosomal dominant polycystic kidney patients undergoing native nephrectomy with renal transplantation: a contemporary analysis. J. Urol. 2021; 206: e647. 5 Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J. Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann. R. Coll. Surg. Engl. 2011; 93: 391–5. 6 Sultan S, Finn C, Craig-Schapiro R et al. Simultaneous living donor renal transplant and laparoscopic native nephrectomy: an approach to kidney transplant candidates with suspected renal-cell carcinoma. J. Endourol. 2021; 35: 1001–5. 7 Pham PT, Pham PA, Pham PC, Parikh S, Danovitch G. Evaluation of adult renal transplant candidates. Semin. Dial. 2010; 23: 595–605. 8 Stewart-Merrill SB, Thompson RH, Boorjian SA et al. Oncologic surveillance after surgical…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free